These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


69 related items for PubMed ID: 829644

  • 1. [Pharmacogenic tardive dyskinesias and their management].
    Böszörményi Z.
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():95-9. PubMed ID: 829644
    [Abstract] [Full Text] [Related]

  • 2. Reserpine and alpha-methyldopa in the treatment of tardive dyskinesia.
    Huang CC, Wang RI, Hasegawa A, Alverno L.
    Psychopharmacology (Berl); 1981; 73(4):359-62. PubMed ID: 6789358
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of reserpine and alpha-methyldopa in the treatment of tardive dyskinesia.
    Huang CC, Wang RI, Hasegawa A, Alverno L.
    Psychopharmacol Bull; 1980 Jul; 16(3):41-3. PubMed ID: 7403399
    [No Abstract] [Full Text] [Related]

  • 4. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV, Montejo González AL, Martín Carrasco M.
    Actas Esp Psiquiatr; 2003 Jul; 31(6):347-52. PubMed ID: 14639511
    [Abstract] [Full Text] [Related]

  • 5. [Tardive dyskinesia. Synthetic-critical review and case contribution].
    Campanini T, Catalano A, De Risio C, Forino V.
    Ateneo Parmense Acta Biomed; 1977 Jul; 48(1):41-60. PubMed ID: 324489
    [Abstract] [Full Text] [Related]

  • 6. Added amantadine may diminish tardive dyskinesia in patients requiring continued neuroleptics.
    Freudenreich O, McEvoy JP.
    J Clin Psychiatry; 1995 Apr; 56(4):173. PubMed ID: 7713860
    [No Abstract] [Full Text] [Related]

  • 7. A therapeutic approach to tardive dyskinesia.
    Fahn S.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474
    [Abstract] [Full Text] [Related]

  • 8. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH.
    Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia].
    Karniol IG, Giampietro AC, Moura DS, Vilela WA, Oliveira MA, Zuardi AW.
    Acta Psiquiatr Psicol Am Lat; 1983 Dec; 29(4):261-6. PubMed ID: 6369888
    [Abstract] [Full Text] [Related]

  • 14. [Drug therapy in tardive dyskinesia].
    Neumann NU.
    Fortschr Med; 1980 Nov 13; 98(42):1636-40. PubMed ID: 7461556
    [No Abstract] [Full Text] [Related]

  • 15. Stable remission of tardive dyskinesia by L-dopa.
    Ludatscher JI.
    J Clin Psychopharmacol; 1989 Feb 13; 9(1):39-41. PubMed ID: 2565346
    [Abstract] [Full Text] [Related]

  • 16. Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents.
    Fahn S.
    Adv Neurol; 1983 Feb 13; 37():267-76. PubMed ID: 6858776
    [Abstract] [Full Text] [Related]

  • 17. [Tardive dyskinesia caused by neuroleptics. Survey of 3,140 psychiatric hospital patients].
    Bourgeois M, Tignol J.
    Nouv Presse Med; 1977 Nov 19; 6(39):3649-50. PubMed ID: 607184
    [No Abstract] [Full Text] [Related]

  • 18. Tardive dyskinesia in patients receiving lithium maintenance therapy.
    Perényi A, Szücs R, Frecska E.
    Biol Psychiatry; 1984 Nov 19; 19(11):1573-8. PubMed ID: 6151403
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of 37 cases of tardive dyskinesia by deanol].
    Cai N.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug 19; 18(4):234-6. PubMed ID: 4075918
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of tardive dyskinesia caused by neuroleptics].
    Piccinin GL, Piccirilli M, Rizzo PA.
    Riv Neurol; 1984 Aug 19; 54(3):199-215. PubMed ID: 6147888
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.